Copyright
©The Author(s) 2024.
World J Diabetes. Apr 15, 2024; 15(4): 769-782
Published online Apr 15, 2024. doi: 10.4239/wjd.v15.i4.769
Published online Apr 15, 2024. doi: 10.4239/wjd.v15.i4.769
Figure 2 Icariin enhanced the expression of osteogenesis-related markers.
A: Expression levels of osteogenesis-related genes [alkaline phosphatase (ALP), osteocalcin (OCN), runt-related transcription factor 2 (RUNX2), and collagen type I alpha 1 (COL1A1)] in bone marrow mesenchymal stem cells (BMSCs) following treatment with icariin (ICA); B: Protein expression levels of ALP and OCN by Western blot; C: Expression of ALP by immunofluorescence (scale bar: 100 μm); D: Expression of OCN by immunofluorescence (scale bar: 100 μm). Data are mean ± SEM (n = 5). bP < 0.01 vs control group; cP < 0.05 and dP < 0.01 vs 1 μM ICA group. ICA: Icariin; ALP: Alkaline phosphatase; OCN: Osteocalcin; RUNX2: Runt-related transcription factor 2; COL1A1: Collagen type I alpha 1; qRT-PCR: Quantitative real-time polymerase chain reaction.
- Citation: Zheng S, Hu GY, Li JH, Zheng J, Li YK. Icariin accelerates bone regeneration by inducing osteogenesis-angiogenesis coupling in rats with type 1 diabetes mellitus. World J Diabetes 2024; 15(4): 769-782
- URL: https://www.wjgnet.com/1948-9358/full/v15/i4/769.htm
- DOI: https://dx.doi.org/10.4239/wjd.v15.i4.769